As of 2025-09-16, the Relative Valuation of Reata Pharmaceuticals Inc (RETA) is (51.13) USD. This relative valuation is based on P/E multiples. With the latest stock price at 172.36 USD, the upside of Reata Pharmaceuticals Inc based on Relative Valuation is -129.7%.
The range of the Relative Valuation is (49.62) - (51.81) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 19.9x | 18.9x |
| Forward P/E multiples | 19.0x - 21.7x | 20.3x |
| Fair Price | (49.62) - (51.81) | (51.13) |
| Upside | -128.8% - -130.1% | -129.7% |
| Date | P/E |